Page last updated: 2024-10-20

pyridoxal and Diabetes Mellitus, Type 1

pyridoxal has been researched along with Diabetes Mellitus, Type 1 in 3 studies

Diabetes Mellitus, Type 1: A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ahmad, S1
Shahab, U1
Habib, S1
Salman Khan, M1
Alam, K1
Ali, A1
Beder, I1
Kittova, M1
Mataseje, A1
Carsky, J1
Orszaghova, Z1
Babinska, K1
Wilson, RG1
Davis, RE1

Trials

1 trial available for pyridoxal and Diabetes Mellitus, Type 1

ArticleYear
The effect of selected membrane active substances on erythrocyte deformability.
    Bratislavske lekarske listy, 2003, Volume: 104, Issue:2

    Topics: Adult; Antioxidants; Diabetes Mellitus, Type 1; Erythrocyte Deformability; Erythrocyte Membrane; Gua

2003

Other Studies

2 other studies available for pyridoxal and Diabetes Mellitus, Type 1

ArticleYear
Glycoxidative damage to human DNA: Neo-antigenic epitopes on DNA molecule could be a possible reason for autoimmune response in type 1 diabetes.
    Glycobiology, 2014, Volume: 24, Issue:3

    Topics: Autoimmunity; Deoxyguanosine; Diabetes Mellitus, Type 1; DNA; DNA Damage; Epitopes; Glycation End Pr

2014
Serum pyridoxal concentrations in children with diabetes mellitus.
    Pathology, 1977, Volume: 9, Issue:2

    Topics: Adolescent; Adult; Child; Child, Preschool; Diabetes Mellitus, Type 1; Female; Humans; Male; Pyridox

1977